HomeAdministrativeBilling & ReimbursementBlueCardHealth and WellnessMedicalNaviNet OpenPharmacyProductsQuality Management

Opioid AwarenessPharmacy

Reminder: Prior authorization update regarding low-dose opioid therapy 

February 1, 2019    

As of July 1, 2017, Independence placed a five-day supply limit on all low-dose opioids. Members who, at that time, already had a prescription for greater than a five-day supply of low-dose opioids were temporarily exempted from this limit.

As a reminder, beginning March 1, 2019, all members, including those previously exempt, will require a prior authorization when continuing low-dose opioid therapy beyond five days, if they have not already received prior authorization approval from Independence. Providers will receive a letter with a list of their Independence patients who are affected by this change.

For more details regarding opioid and non-opioid therapy options, please refer to the CDC’s Checklist for prescribing opioids for chronic pain.

If you have any questions concerning the prior authorization process, please contact FutureScripts®, our pharmacy benefits manager, at 1-888-678-7012.

FutureScripts is an independent company that provides pharmacy benefits management services.





Connect with us    Facebook     Twitter     Flickr     YouTube    Walk the Talk   Independence Pinterest   Independence Google+   Independence LinkedIn   Independence InstagramSite Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2019 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.